Resveratrol sensitized leukemia stem cell-like KG-1a cells to cytokine-induced killer cells-mediated cytolysis through NKG2D ligands and TRAIL receptors

Resistance to Cytarabine Induces the Up-regulation of NKG2D Ligands and Enhances Natural Killer Cell Lysis of Leukemic Cells

(2015) Henry Ogbomo et al.   NEOPLASIA

The anti-tumour activity of allogeneic cytokine-induced killer cells in patients who relapse after allogeneic transplant for haematological malignancies

(2011) Y-C Linn et al.   BONE MARROW TRANSPLANTATION

Chemotherapy-resistant osteosarcoma is highly susceptible to IL-15-activated allogeneic and autologous NK cells

(2011) Emilie P. Buddingh et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Targeting the extrinsic apoptosis signaling pathway for cancer therapy

(2011) Thomas J. Sayers   CANCER IMMUNOLOGY IMMUNOTHERAPY

Resistance of leukemic stem-like cells in AML cell line KG1a to natural killer cell-mediated cytotoxicity

(2011) Miaorong She et al.   CANCER LETTERS

The cytotoxic potential of interleukin-15-stimulated cytokine-induced killer cells against leukemia cells

(2011) Eva Rettinger et al.   CYTOTHERAPY

Molecular targets for selective killing of TRAIL-resistant leukemic cells

(2011) Giorgio Zauli et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Anti-tumor and immunomodulatory activity of resveratrol in vitro and its potential for combining with cancer immunotherapy

(2011) Brenda L. Soto et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Leukemia stem cells

(2011) Eike C. Buss et al.   INTERNATIONAL JOURNAL OF CANCER

Leukemia Stem Cells and Microenvironment: Biology and Therapeutic Targeting

(2011) Marina Y. Konopleva et al.   JOURNAL OF CLINICAL ONCOLOGY

Cancer Immunoediting of the NK Group 2D Ligand H60a

(2011) T. O'Sullivan et al.   JOURNAL OF IMMUNOLOGY

Implications of cancer stem cell theory for cancer chemoprevention by natural dietary compounds

(2011) Yanyan Li et al.   JOURNAL OF NUTRITIONAL BIOCHEMISTRY

Resveratrol Triggers Apoptosis Through Regulating Ceramide Metabolizing Genes in Human K562 Chronic Myeloid Leukemia Cells

(2011) Melis Kartal et al.   NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL

Molecular Pathways for Cancer Chemoprevention by Dietary Phytochemicals

(2011) Aaron C. Tan et al.   NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL

Molecular pathology of tumor-initiating cells: Lessons from Philadelphia chromosome-positive leukemia

(2011) Kazuhito Naka et al.   PATHOLOGY INTERNATIONAL

Resveratrol Inhibits Pancreatic Cancer Stem Cell Characteristics in Human and KrasG12D Transgenic Mice by Inhibiting Pluripotency Maintaining Factors and Epithelial-Mesenchymal Transition

(2011) Sharmila Shankar et al.   PLoS One

Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion

(2011) R. D. Schreiber et al.   SCIENCE

Expression of the RAE-1 Family of Stimulatory NK-Cell Ligands Requires Activation of the PI3K Pathway during Viral Infection and Transformation

(2011) Maria Tokuyama et al.   PLoS Pathogens

Salinomycin overcomes ABC transporter-mediated multidrug and apoptosis resistance in human leukemia stem cell-like KG-1a cells

(2010) Dominik Fuchs et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Resveratrol suppresses IGF-1 induced human colon cancer cell proliferation and elevates apoptosis via suppression of IGF-1R/Wnt and activation of p53 signaling pathways

(2010) Jairam Vanamala et al.   BMC CANCER

Resveratrol suppresses growth of cancer stem-like cells by inhibiting fatty acid synthase

(2010) Puspa R. Pandey et al.   BREAST CANCER RESEARCH AND TREATMENT

Resveratrol enhances the anti-tumor activity of the mTOR inhibitor rapamycin in multiple breast cancer cell lines mainly by suppressing rapamycin-induced AKT signaling

(2010) Xin He et al.   CANCER LETTERS

Combining naturally occurring polyphenols with TNF-related apoptosis-inducing ligand: a promising approach to kill resistant cancer cells?

(2010) Guillaume Jacquemin et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

IL-15 induces CD8+ T cells to acquire functional NK receptors capable of modulating cytotoxicity and cytokine secretion

(2010) Margareta P. Correia et al.   IMMUNOBIOLOGY

The roles of bioactive sphingolipids in resveratrol-induced apoptosis in HL60 acute myeloid leukemia cells

(2010) Zeynep Cakir et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Quercetin Enhances Susceptibility to NK Cell-mediated Lysis of Tumor Cells Through Induction of NKG2D Ligands and Suppression of HSP70

(2010) Jae-Ho Bae et al.   JOURNAL OF IMMUNOTHERAPY

Cancer Prevention With Natural Compounds

(2010) Norleena P. Gullett et al.   SEMINARS IN ONCOLOGY

The allogeneic graft-versus-cancer effect

(2009) Olle Ringdén et al.   BRITISH JOURNAL OF HAEMATOLOGY

Molecular crosstalk between TRAIL and natural antioxidants in the treatment of cancer

(2009) Stuart A Rushworth et al.   BRITISH JOURNAL OF PHARMACOLOGY

Sodium butyrate upregulates expression of NKG2D ligand MICA/B in HeLa and HepG2 cell lines and increases their susceptibility to NK lysis

(2009) Cai Zhang et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Evaluation of anti-leukemia effect of resveratrol by modulating SATA3 signaling

(2009) Tan Li et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Resveratrol Alters Proliferative Responses and Apoptosis in Human Activated B Lymphocytes in Vitro

(2009) Susan J. Zunino et al.   JOURNAL OF NUTRITION

Involvement of mitochondria and recruitment of Fas/CD95 signaling in lipid rafts in resveratrol-mediated antimyeloma and antileukemia actions

(2009) M Reis-Sobreiro et al.   ONCOGENE

Direct and Natural Killer Cell-Mediated Antitumor Effects of Low-Dose Bortezomib in Hepatocellular Carcinoma

(2008) S. Armeanu et al.   CLINICAL CANCER RESEARCH

Resveratrol Exerts Antiproliferative Activity and Induces Apoptosis in Waldenstrom's Macroglobulinemia

(2008) A. M. Roccaro et al.   CLINICAL CANCER RESEARCH

Decreased Dicer expression elicits DNA damage and up-regulation of MICA and MICB

(2008) Kai-Fu Tang et al.   JOURNAL OF CELL BIOLOGY

NK cells and cancer immunosurveillance

(2008) I Waldhauer et al.   ONCOGENE

NKG2D ligands: key targets of the immune response

(2008) Segundo González et al.   TRENDS IN IMMUNOLOGY